Responses to avapritinib in patients with advanced systemic mastocytosis
0 Views
administrator
07/09/23
Tracy George, MD, ARUP Laboratories, University of Utah, Salt Lake City, UT, discusses the efficacy of avapritinib in patients with advanced systemic mastocytosis. In this video, Dr George highlights the decrease in mast cell burden and hypercellularity in the bone marrow and the promise of this agent for the treatment of systemic mastocytosis. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
-
Category
Show more
Facebook Comments
No comments found